Literature DB >> 2504520

Interferon-gamma treatment increases HLA-DR expression on monocytes in severely injured patients.

M J Hershman1, S H Appel, S R Wellhausen, G Sonnenfeld, H C Polk.   

Abstract

Traumatic injury and sepsis reduce HLA-DR expression on monocytes. This study assessed the effect of interferon-gamma (IFN-gamma) on the expression of HLA-DR on monocytes taken from severely injured patients. The mononuclear layer of each blood sample was incubated with either 500 units IFN-gamma or control media. The mean baseline HLA-DR expression of the trauma group (n = 11) was 32%, significantly less than the mean HLA-DR expression of 91% for the control group (n = 10). In the trauma group, HLA-DR expression after culturing with IFN-gamma was 81%, significantly greater than both the mean baseline HLA-DR expression (32%). In the control group, HLA-DR expression after culturing with IFN-gamma was 94%, similar to the mean baseline HLA-DR expression of 91%. These data confirm that HLA-DR on monocytes of severely injured patients is markedly reduced and show that it can be increased significantly in vitro by IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2504520      PMCID: PMC1541937     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

1.  A systematic study of host defense processes in badly injured patients.

Authors:  H C Polk; C D George; S R Wellhausen; K Cost; P R Davidson; M P Regan; A P Borzotta
Journal:  Ann Surg       Date:  1986-09       Impact factor: 12.969

2.  The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care.

Authors:  S P Baker; B O'Neill; W Haddon; W B Long
Journal:  J Trauma       Date:  1974-03

Review 3.  Mhc restriction and Ir genes.

Authors:  J Klein; Z A Nagy
Journal:  Adv Cancer Res       Date:  1982       Impact factor: 6.242

4.  Decreased expression of human class II antigens on monocytes from patients with acquired immune deficiency syndrome. Increased expression with interferon-gamma.

Authors:  W Heagy; V E Kelley; T B Strom; K Mayer; H M Shapiro; R Mandel; R Finberg
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

5.  Preferential effect of gamma interferon on the synthesis of HLA antigens and their mRNAs in human cells.

Authors:  D Wallach; M Fellous; M Revel
Journal:  Nature       Date:  1982-10-28       Impact factor: 49.962

6.  Depression of cellular immunity after multiple trauma in the absence of sepsis.

Authors:  J B O'Mahony; S B Palder; J J Wood; A McIrvine; M L Rodrick; R H Demling; J A Mannick
Journal:  J Trauma       Date:  1984-10

7.  Decrease in HLA-DR-positive monocytes in patients with systemic lupus erythematosus (SLE).

Authors:  F Shirakawa; U Yamashita; H Suzuki
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

8.  Decreased expression of class II major histocompatibility antigens on monocytes from patients with Hodgkin's disease.

Authors:  H Nagai; R I Fisher; J Cossman; J J Oppenheim
Journal:  J Leukoc Biol       Date:  1986-03       Impact factor: 4.962

9.  Recombinant interferon-gamma increases HLA-DR synthesis and expression.

Authors:  T Y Basham; T C Merigan
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

10.  Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity.

Authors:  P S Steeg; R N Moore; H M Johnson; J J Oppenheim
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

  10 in total
  21 in total

Review 1.  Jaks, STATs, Cytokines, and Sepsis.

Authors:  Melanie J Scott; Christopher J Godshall; William G Cheadle
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

2.  The acute pulmonary inflammatory response to the graded severity of smoke inhalation injury.

Authors:  Joslyn M Albright; Christopher S Davis; Melanie D Bird; Luis Ramirez; Hajwa Kim; Ellen L Burnham; Richard L Gamelli; Elizabeth J Kovacs
Journal:  Crit Care Med       Date:  2012-04       Impact factor: 7.598

3.  Reduction in HLA-DR antigen density on alveolar macrophages of smokers.

Authors:  W Pankow; K Neumann; J Rüschoff; R Schröder; P von Wichert
Journal:  Lung       Date:  1991       Impact factor: 2.584

Review 4.  Immunoparalysis and adverse outcomes from critical illness.

Authors:  W Joshua Frazier; Mark W Hall
Journal:  Pediatr Clin North Am       Date:  2008-06       Impact factor: 3.278

5.  Interferon gamma in trauma-related infections.

Authors:  D J Dries
Journal:  Intensive Care Med       Date:  1996-10       Impact factor: 17.440

6.  Rationale, design and performance of a clinical trial to investigate interferon-gamma (Imukin) in the prophylactic treatment of severe burns-related infections.

Authors:  J D Ioannovich; R D Hinzmann; G Deichsel; G G Steinmann
Journal:  Intensive Care Med       Date:  1996-10       Impact factor: 17.440

Review 7.  The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients.

Authors:  Nicholas S Ward; Brian Casserly; Alfred Ayala
Journal:  Clin Chest Med       Date:  2008-12       Impact factor: 2.878

8.  CD40-CD154 interactions between macrophages and natural killer cells during sepsis are critical for macrophage activation and are not interferon gamma dependent.

Authors:  M J Scott; J J Hoth; M K Stagner; S A Gardner; J C Peyton; W G Cheadle
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

9.  Mannitol upregulates monocyte HLA-DR, monocyte and neutrophil CD11b, and inhibits neutrophil apoptosis.

Authors:  Matthias Turina; Aaron Mulhall; Sarah Gardner; Hiram C Polk; Frederick N Miller
Journal:  Inflammation       Date:  2008-04       Impact factor: 4.092

10.  Is low monocyte HLA-DR expression helpful to predict outcome in severe sepsis?

Authors:  Sara E Perry; Sobhy M Mostafa; Richard Wenstone; Alan Shenkin; Paul J McLaughlin
Journal:  Intensive Care Med       Date:  2003-05-28       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.